Home › Funds › SILVERARC CAPITAL MANAGEMENT, LLC › ZVRA
SILVERARC CAPITAL MANAGEMENT, LLC position in ZVRA
ZEVRA THERAPEUTICS INC · Health Care
SILVERARC CAPITAL MANAGEMENT, LLC reported holding 200,260 shares of ZVRA (ZEVRA THERAPEUTICS INC) in its Q3 2026 13F filing — a position valued at US$2.2M, representing 0.28% of its reported portfolio and ranking #50 among its reported holdings. SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ZVRA holdings in 2 of the last 9 reported quarters, going back to Q3 2024.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How SILVERARC CAPITAL MANAGEMENT, LLC's ZVRA position evolved
SILVERARC CAPITAL MANAGEMENT, LLC first disclosed a stake in ZVRA in Q3 2024 at 350,000 shares (US$2.4M). Across 2 filings, SILVERARC CAPITAL MANAGEMENT, LLC held the position steady without any share-count change. The most recent filing (Q3 2026) shows 200,260 shares valued at US$2.2M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2024 | 350.00K | $2.43M | New |
| Q3 2026 | 200.26K | $2.20M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ZVRA and 13F data
ZVRA (ZEVRA THERAPEUTICS INC) is a Health Care company. 51 other funds we track also report a position in ZVRA — the largest reported positions include Nantahala Capital Management, LLC (US$25.8M), 683 Capital Management, LLC (US$12.3M), KINGDON CAPITAL MANAGEMENT, L.L.C. (US$11.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ZVRA
- Nantahala Capital Management, LLC 1.80M sh · $25.78M · Q2 2026
- 683 Capital Management, LLC 855.00K sh · $12.26M · Q2 2026
- KINGDON CAPITAL MANAGEMENT, L.L.C. 775.00K sh · $11.11M · Q2 2026
- Retirement Planning Co of New England, Inc. 612.33K sh · $6.72M · Q3 2026
- Mystic Asset Management, Inc. 355.38K sh · $3.90M · Q3 2026
- Stonepine Capital Management, LLC 258.70K sh · $3.71M · Q2 2026
- Diametric Capital, LP 231.47K sh · $3.32M · Q2 2026
More on SILVERARC CAPITAL MANAGEMENT, LLC
FAQ
How long has SILVERARC CAPITAL MANAGEMENT, LLC held ZVRA?
SILVERARC CAPITAL MANAGEMENT, LLC has disclosed ZVRA holdings in 2 of the last 9 reported quarters, going back to Q3 2024.
What is SILVERARC CAPITAL MANAGEMENT, LLC's current position in ZVRA?
As of Q3 2026, SILVERARC CAPITAL MANAGEMENT, LLC holds 200.26K shares of ZVRA (ZEVRA THERAPEUTICS INC), valued at $2.20M, representing 0.28% of its reported portfolio and ranking #50.
Has SILVERARC CAPITAL MANAGEMENT, LLC been buying or selling ZVRA?
In the latest 13F filing (Q3 2026), SILVERARC CAPITAL MANAGEMENT, LLC newly opened its position in ZVRA.
Which other funds hold ZVRA?
Other major institutional holders of ZVRA include Nantahala Capital Management, LLC, 683 Capital Management, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., among 51 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.